Search research articles
Contact Us
Filters
Showing results (581-590 of 954) with videos related to
Page
of 96
Sort By:
The Journal of Nutrition
|
May 1, 1999
Select 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition
R G Elkin, Z Yan, Y Zhong, et al.
Physical Review Letters
|
November 15, 2024
Continuum Excitations in a Spin Supersolid on a Triangular Lattice
M Zhu, V Romerio, N Steiger, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 9, 2022
[A clinical retrospective analysis of newly diagnosed multiple myeloma patients with systemic light chain amyloidosis]
Y Liu, H Y You, L Z Yan, et al.
Nature Communications
|
May 4, 2022
Genome and transcriptome mechanisms driving cephalopod evolution
Caroline B Albertin, Sofia Medina-Ruiz, Therese Mitros, et al.
Cancer Research
|
December 5, 2000
Frequent amplification of the telomerase reverse transcriptase gene in human tumors
A Zhang, C Zheng, C Lindvall, et al.
Oncogenesis
|
February 16, 2016
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
Z Fan, H Cui, H Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 28, 2023
[Multiple myeloma with chromothripsis: three cases report]
C X Wu, Z Zeng, Q R Wang, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 24, 2017
A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia
H-L Peng, Y Zhang, N-N Sun, et al.
Oncogenesis
|
October 4, 2016
The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway
H Mai, X Xu, G Mei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 2006
N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases
Z Yan, G W Caldwell, D Gauthier, et al.
Page
of 96
Search research articles
Search
Showing results (581-590 of 954) with videos related to
Sort By:
Page
of 96
The Journal of Nutrition
|
May 1, 1999
Select 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors vary in their ability to reduce egg yolk cholesterol levels in laying hens through alteration of hepatic cholesterol biosynthesis and plasma VLDL composition
R G Elkin, Z Yan, Y Zhong, et al.
Physical Review Letters
|
November 15, 2024
Continuum Excitations in a Spin Supersolid on a Triangular Lattice
M Zhu, V Romerio, N Steiger, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
June 9, 2022
[A clinical retrospective analysis of newly diagnosed multiple myeloma patients with systemic light chain amyloidosis]
Y Liu, H Y You, L Z Yan, et al.
Nature Communications
|
May 4, 2022
Genome and transcriptome mechanisms driving cephalopod evolution
Caroline B Albertin, Sofia Medina-Ruiz, Therese Mitros, et al.
Cancer Research
|
December 5, 2000
Frequent amplification of the telomerase reverse transcriptase gene in human tumors
A Zhang, C Zheng, C Lindvall, et al.
Oncogenesis
|
February 16, 2016
MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
Z Fan, H Cui, H Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|
January 28, 2023
[Multiple myeloma with chromothripsis: three cases report]
C X Wu, Z Zeng, Q R Wang, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 24, 2017
A gain-of-function mutation in TNFRSF13B is a candidate for predisposition to familial or sporadic immune thrombocytopenia
H-L Peng, Y Zhang, N-N Sun, et al.
Oncogenesis
|
October 4, 2016
The interplay between HPIP and casein kinase 1α promotes renal cell carcinoma growth and metastasis via activation of mTOR pathway
H Mai, X Xu, G Mei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 2006
N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases
Z Yan, G W Caldwell, D Gauthier, et al.
Page
of 96